loading
Precedente Chiudi:
$4.60
Aprire:
$4.68
Volume 24 ore:
94,334
Relative Volume:
0.53
Capitalizzazione di mercato:
$330.39M
Reddito:
$77.27M
Utile/perdita netta:
$-79.00M
Rapporto P/E:
-3.9422
EPS:
-1.1694
Flusso di cassa netto:
$-48.46M
1 W Prestazione:
+5.98%
1M Prestazione:
-2.74%
6M Prestazione:
+47.76%
1 anno Prestazione:
+47.76%
Intervallo 1D:
Value
$4.5501
$4.74
Intervallo di 1 settimana:
Value
$4.275
$4.74
Portata 52W:
Value
$2.58
$5.70

Sophia Genetics Sa Stock (SOPH) Company Profile

Name
Nome
Sophia Genetics Sa
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
415
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-04
Name
Ultimi documenti SEC
Name
SOPH's Discussions on Twitter

Compare SOPH vs VEEV, TEM, BTSG, HQY, WAY

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
SOPH
Sophia Genetics Sa
4.61 330.39M 77.27M -79.00M -48.46M -1.1694
Health Information Services icon
VEEV
Veeva Systems Inc
178.88 29.40B 3.20B 908.91M 1.42B 5.4155
Health Information Services icon
TEM
Tempus Ai Inc
49.98 8.94B 1.27B -245.03M -245.36M -1.4071
Health Information Services icon
BTSG
Brightspring Health Services Inc
38.31 7.36B 12.91B 104.80M 394.69M 0.8769
Health Information Services icon
HQY
Healthequity Inc
77.81 6.65B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
24.16 4.63B 1.10B 112.09M 283.19M 0.6096

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-18 Iniziato Craig Hallum Buy
2024-08-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-06-27 Iniziato Guggenheim Buy
2023-11-29 Iniziato RBC Capital Mkts Outperform
2023-07-05 Ripresa JP Morgan Overweight
2023-01-03 Iniziato BTIG Research Buy
2022-11-23 Iniziato Credit Suisse Neutral
2021-10-15 Ripresa Cowen Outperform
2021-08-17 Iniziato Cowen Outperform
2021-08-17 Iniziato Credit Suisse Outperform
2021-08-17 Iniziato JP Morgan Overweight
2021-08-17 Iniziato Morgan Stanley Overweight
Mostra tutto

Sophia Genetics Sa Borsa (SOPH) Ultime notizie

pulisher
Mar 09, 2026

[EFFECT] SOPHiA GENETICS SA SEC Filing - Stock Titan

Mar 09, 2026
pulisher
Mar 08, 2026

Sophia Genetics Earnings Call: Growth Surges, Losses Linger - TipRanks

Mar 08, 2026
pulisher
Mar 07, 2026

Aug PreEarnings: Can SOPHiA GENETICS SA stock double in the next yearJuly 2025 Momentum & High Yield Equity Trading Tips - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns - Sahm

Mar 06, 2026
pulisher
Mar 05, 2026

Will SOPHiA GENETICS SA stock go up in YEARQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 05, 2026

SOPHiA GENETICS Q4 Earnings Call Highlights - Defense World

Mar 05, 2026
pulisher
Mar 04, 2026

Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Mar 04, 2026
pulisher
Mar 04, 2026

SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 04, 2026
pulisher
Mar 03, 2026

BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026 - Meyka

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS (NASDAQ: SOPH) registers 75,000 warrant shares for resale - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

BTIG reiterates Sophia Genetics stock rating on customer growth - Investing.com

Mar 03, 2026
pulisher
Mar 03, 2026

Fulgent Genetics (FLGT) Earnings Transcript - AOL.com

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS S.A. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 - Finviz

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript - The Globe and Mail

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS SA reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS SA 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-03-03 - Seeking Alpha

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Sophia Genetics reports fourth quarter and full year 2025 results - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS (SOPH) 2025 20-F flags losses, platform and regulatory risks - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC FilingForm 6-K - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Sophia Genetics Q4 Earnings Summary & Key TakeawaysSophia Genetics (NASDAQ:SOPH) - Benzinga

Mar 03, 2026
pulisher
Mar 03, 2026

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results - PR Newswire

Mar 03, 2026
pulisher
Mar 02, 2026

A Look at Sophia Genetics's Upcoming Earnings ReportSophia Genetics (NASDAQ:SOPH) - Benzinga

Mar 02, 2026
pulisher
Mar 01, 2026

SOPHiA GENETICS (SOPH) to Release Earnings on Tuesday - Defense World

Mar 01, 2026
pulisher
Feb 27, 2026

SOPH Should I Buy - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

SOPHiA GENETICS SA expected to post a loss of 24 cents a shareEarnings Preview - TradingView

Feb 27, 2026
pulisher
Feb 26, 2026

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Expands By 194.3% - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Why The SOPHiA GENETICS (SOPH) Narrative Is Shifting On Richer Valuation And Growth Expectations - Yahoo Finance UK

Feb 26, 2026
pulisher
Feb 25, 2026

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference - Finviz

Feb 25, 2026
pulisher
Feb 25, 2026

SOPHiA GENETICS CEO, president in TD Cowen fireside chat March 4 - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

SOPHiA GENETICS (SOPH) Projected to Announce Earnings on Tuesday - MarketBeat

Feb 24, 2026
pulisher
Feb 19, 2026

760 RSUs flagged for sale at Sophic Biosciences (NASDAQ: SOPH) — insider filing - Stock Titan

Feb 19, 2026
pulisher
Feb 18, 2026

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million - AOL.com

Feb 18, 2026
pulisher
Feb 18, 2026

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough - AOL.com

Feb 18, 2026
pulisher
Feb 16, 2026

Swiss–Japanese Partnership Advances Precision Oncology through Liquid Biopsy and Companion Diagnostics - S-GE

Feb 16, 2026
pulisher
Feb 15, 2026

Can SOPHiA GENETICS SA continue delivering strong returns2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Aug Patterns: Will SOPHiA GENETICS SA stock go up in YEARQuarterly Performance Summary & Reliable Price Breakout Alerts - baoquankhu1.vn

Feb 15, 2026
pulisher
Feb 15, 2026

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat

Feb 15, 2026
pulisher
Feb 13, 2026

Moderna Just Crushed Estimates While Everyone Was Looking the Other Way - AOL.com

Feb 13, 2026
pulisher
Feb 12, 2026

Can SOPHiA GENETICS SA (90B) stock deliver double digit returnsJobs Report & Free Safe Capital Growth Stock Tips - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Is SOPHiA GENETICS SA a potential multi baggerJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Why The Story Behind SOPHiA GENETICS (SOPH) Is Shifting After The Latest Target Reset - Yahoo Finance

Feb 11, 2026
pulisher
Feb 10, 2026

Day Trade: Can SOPHiA GENETICS SA sustain its profitabilityJuly 2025 Action & Long-Term Investment Growth Plans - baoquankhu1.vn

Feb 10, 2026
pulisher
Feb 10, 2026

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems - Finviz

Feb 10, 2026
pulisher
Feb 10, 2026

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems – Company AnnouncementFT.com - Financial Times

Feb 10, 2026
pulisher
Feb 10, 2026

SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer - Quantisnow

Feb 10, 2026
pulisher
Feb 08, 2026

Aug Wrap: Can SOPHiA GENETICS SA sustain its profitability2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 06, 2026

Painful week for individual investors invested in SOPHiA GENETICS SA (NASDAQ:SOPH) after 11% drop, institutions also suffered losses - simplywall.st

Feb 06, 2026
pulisher
Feb 03, 2026

VIX Spike: Is SOPHiA GENETICS SA benefiting from interest rate changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - baoquankhu1.vn

Feb 03, 2026
pulisher
Jan 31, 2026

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 68.3% - MarketBeat

Jan 31, 2026

Sophia Genetics Sa Azioni (SOPH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
health_information_services TXG
$18.79
price down icon 0.79%
$21.68
price down icon 0.23%
$45.00
price up icon 1.21%
$15.76
price down icon 4.66%
$24.37
price up icon 0.37%
health_information_services WAY
$24.16
price down icon 1.83%
Capitalizzazione:     |  Volume (24 ore):